Literature DB >> 17464182

Identification of novel substrates for human checkpoint kinase Chk1 and Chk2 through genome-wide screening using a consensus Chk phosphorylation motif.

Myoung-Ae Kim1, Hyun-Ju Kim, Alexandra L Brown, Min-Young Lee, Yoe-Sik Bae, Joo-In Park, Jong-Young Kwak, Jay H Chung, Jeanho Yun.   

Abstract

Checkpoint kinase 1 (Chk1) and Chk2 are effector kinases in the cellular DNA damage response and impairment of their function is closely related to tumorigenesis. Previous studies revealed several substrate proteins of Chk1 and Chk2, but identification of additional targets is still important in order to understand their tumor suppressor functions. In this study, we screened novel substrates for Chk1 and Chk2 using substrate target motifs determined previously by an oriented peptide library approach. The potential candidates were selected by genome-wide peptide database searches and were examined by in vitro kinase assays. ST5, HDAC5, PGC-1alpha, PP2A PR130, FANCG, GATA3, cyclin G, Rad51D and MAD1a were newly identified as in vitro substrates for Chk1 and/or Chk2. Among these, HDAC5 and PGC-1a were further analyzed to substantiate the screening results. Immunoprecipitation kinase assay of full-length proteins and site-directed mutagenesis analysis of the target motifs demonstrated that HDAC5 and PGC-1alpha were specific targets for Chk1 and/or Chk2 at least in vitro.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17464182     DOI: 10.1038/emm.2007.23

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  18 in total

Review 1.  The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men.

Authors:  Xiang-Jiao Yang; Edward Seto
Journal:  Nat Rev Mol Cell Biol       Date:  2008-03       Impact factor: 94.444

2.  Glucose deprivation is associated with Chk1 degradation through the ubiquitin-proteasome pathway and effective checkpoint response to replication blocks.

Authors:  Ae Jeong Kim; Hyun-Ju Kim; Hye Jin Jee; Naree Song; Minjee Kim; Yoe-Sik Bae; Jay H Chung; Jeanho Yun
Journal:  Biochim Biophys Acta       Date:  2011-04-01

Review 3.  Lysine deacetylase (KDAC) regulatory pathways: an alternative approach to selective modulation.

Authors:  Michael W Van Dyke
Journal:  ChemMedChem       Date:  2014-01-21       Impact factor: 3.466

4.  Oocyte Elimination Through DNA Damage Signaling from CHK1/CHK2 to p53 and p63.

Authors:  Vera D Rinaldi; Jordana C Bloom; John C Schimenti
Journal:  Genetics       Date:  2020-04-09       Impact factor: 4.562

5.  Multi-transmembrane protein K15 of Kaposi's sarcoma-associated herpesvirus targets Lyn kinase in the membrane raft and induces NFAT/AP1 activities.

Authors:  Nam-Hyuk Cho; Young-Ki Choi; Joong-Kook Choi
Journal:  Exp Mol Med       Date:  2008-10-31       Impact factor: 8.718

Review 6.  Roles of Chk1 in cell biology and cancer therapy.

Authors:  Youwei Zhang; Tony Hunter
Journal:  Int J Cancer       Date:  2013-05-28       Impact factor: 7.396

Review 7.  Centrosome-associated regulators of the G(2)/M checkpoint as targets for cancer therapy.

Authors:  Yingmei Wang; Ping Ji; Jinsong Liu; Russell R Broaddus; Fengxia Xue; Wei Zhang
Journal:  Mol Cancer       Date:  2009-02-13       Impact factor: 27.401

8.  Akt3 knockdown induces mitochondrial dysfunction in human cancer cells.

Authors:  Minjee Kim; Young Yeon Kim; Hye Jin Jee; Sun Sik Bae; Na Young Jeong; Jee-Hyun Um; Jeanho Yun
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-03-13       Impact factor: 3.848

9.  GATA3 induces mitochondrial biogenesis in primary human CD4+ T cells during DNA damage.

Authors:  Lauren A Callender; Johannes Schroth; Elizabeth C Carroll; Conor Garrod-Ketchley; Lisa E L Romano; Eleanor Hendy; Audrey Kelly; Paul Lavender; Arne N Akbar; J Paul Chapple; Sian M Henson
Journal:  Nat Commun       Date:  2021-06-07       Impact factor: 14.919

10.  Fanconi anemia complementation group FANCD2 protein serine 331 phosphorylation is important for fanconi anemia pathway function and BRCA2 interaction.

Authors:  Gang Zhi; James B Wilson; Xiaoyong Chen; Diane S Krause; Yuxuan Xiao; Nigel J Jones; Gary M Kupfer
Journal:  Cancer Res       Date:  2009-10-27       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.